Researchers develop nasal spray H5N1 avian influenza vaccine
The State Key Laboratory for Emerging Infectious Diseases at the University of Hong Kong (HKU) and the InnoHK Center for ...
C&EN27d
Building a better COVID-19 vaccine
the vaccine developed by WashU Medicine uses an adenovirus vector to deliver its payload. Adenoviruses are DNA viruses that have easily modifiable genomes. Scientists can deactivate the genes in ...
Tick-borne disease vaccines: 'IscREAM' library reveals potential targets
New research led by Yale School of Medicine (YSM) advances the goals of creating a diagnostic test and vaccines for ...
MLive25d
Still ‘no red flags’ for COVID vaccine after years of monitoring their safety
More traditional COVID vaccines (vector viral) like the one developed by Johnson & Johnson and Oxford-AstraZeneca were associated with more statistically significant increases in rare adverse ...
EurekAlert!6d
MOPEVACLAS vaccine candidate for Lassa fever enters clinical trials
After more than 20 years of research on arenaviruses, an Institut Pasteur team led by Sylvain Baize has developed an original vaccine platform known as MOPEVAC, which will strengthen the Institut ...
The Poultry Site4d
Two key factors in a robust IBD defense: Speed of replication and onset of immunity
Two important contributors of early protection are speed of replication and onset of immunity, according to Alberto Giner, ...
Medscape21d
Promising Novel Immunotherapies and Combinations for Prostate Cancer
The final Phase III analysis is scheduled in mid 2009. Vector-based vaccines: Vector-based vaccines allow for insertion of multiple genes for TAAs and costimulatory molecules and cytokines.